---
schema_version: "secwatch.filing_event.v1"
accession: "0001549084-22-000029"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:44:28.358830+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# EKSO shareholders approve equity plan share increase and all proposals at annual meeting

## Summary
- Elected six directors; average votes for ~4.2M per nominee, with 2.57M broker non-votes each.
- Approved equity plan amendment raising authorized shares from 1,974,286 to 2,524,286; 3.9M for, 621k against.
- Non-binding say-on-pay approved with 4.24M for, 255k against, 43.6k abstain.
- Ratified WithumSmith+Brown as auditor for FY2022 with 6.99M for, 55.7k against.
- Approximately 7.1M shares voted of 12.8M outstanding, constituting a quorum.

## SEC filing metadata
- accession: 0001549084-22-000029
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000154908422000029/0001549084-22-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000154908422000029/ekso-20220609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001549084-22-000029
- JSON: https://secwatch.observer/filing/0001549084-22-000029.json
- Plain text: https://secwatch.observer/filing/0001549084-22-000029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.